Coamplified and overexpressed genes at ERBB2 locus in gastric cancer
✍ Scribed by Asta Varis; Alexander Zaika; Pauli Puolakkainen; Balint Nagy; Irene Madrigal; Arto Kokkola; Aki Väyrynen; Päivi Kärkkäinen; Christopher Moskaluk; Wa'el El-Rifai; Sakari Knuutila
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 385 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
DNA copy number amplification at the chromosomal region of 17q is frequent in gastric cancer. Recently 17q21 was identified as the critical region for the amplicon formation because this region harbors the ERBB2 oncogene and several other targets, such as TOP2A and DARPP32. In our study, we characterized the amplification (52 cases) and expression (29 cases) levels of ERBB2, TOP2A and DARPP32 in gastric cancer samples. These 3 genes were concomitantly amplified in 17% of the intestinal type of gastric adenocarcinoma. However, the expression levels were independent, showing overexpression of DARPP32 (48%), TOP2A (17%) and ERBB2 (3%) studied by quantitative real‐time PCR. The most frequently overexpressed gene, DARPP32, exhibited strong protein overexpression in 45% (30/66) of the cases in immunohistochemical study of gastric cancer tumor tissue array. Additional studies are required to thoroughly understand the biological significance of these genes in gastric cancer. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Our recent studies using comparative genomic hybridization showed that gain or amplification at the 17q12-q21 region is very common in the intestinal type of gastric cancer. Here, we describe a fluorescence in situ hybridization study with gastrin (GAS)-specific and ERBB2-specific probes on ten spec
## Abstract __SRPX2__ (Sushi repeat containing protein, X‐linked 2) was first identified as a downstream molecule of the __E2A‐HLF__ fusion gene in t(17;19)‐positive leukemia cells and the biological function of this gene remains unknown. We found that __SRPX2__ is overexpressed in gastric cancer a
Background. Amplification and/or overexpression of the C-erbB-2 gene has been demonstrated in breast and gastric cancer and is thought to be involved in the process of gastric cancer metastasis. Methods. The expression of C-erbB-2 protein in human gastric cancer was examined by immunohistochemistry